首页> 外国专利> Antinuclear antibody and anti-CCP in the diagnosis of rheumatoid arthritis

Antinuclear antibody and anti-CCP in the diagnosis of rheumatoid arthritis

机译:抗核抗体和抗CCP在类风湿关节炎的诊断中

摘要

The present invention relates to a method aiding in the assessment of rheumatoid arthritis. The method used for differential diagnosis of rheumatoid arthritis in vitro, particularly. The method, for example, carried out by analysis of biochemical markers comprises determining the concentration of both antinuclear antibodies (ANA) and anti-CCP in the sample is correlated with the diagnosis of rheumatoid arthritis measured concentration is. To further improve the assessment of RA in a method of the present invention, the level of one or more additional marker may be correlated to the absence or presence of RA is measured with ANA and anti-CCP. The present invention relates to the use of a marker panel comprising anti-CCP and ANA in the diagnosis of rheumatoid arthritis and it teaches a kit for performing the method of the present invention.
机译:本发明涉及一种有助于评估类风湿性关节炎的方法。该方法尤其用于体外类风湿关节炎的鉴别诊断。该方法,例如,通过生化标记物的分析来进行,包括确定样品中抗核抗体(ANA)和抗CCP的浓度与风湿性关节炎的诊断所测量的浓度相关。为了在本发明的方法中进一步改善对RA的评估,可以将一种或多种另外的标志物的水平与用ANA和抗CCP测量RA的存在或不存在相关联。本发明涉及包含抗CCP和ANA的标记物组在类风湿性关节炎的诊断中的用途,并且教导了用于执行本发明的方法的试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号